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Psychiatric symptomsAbstract Objective: There is evidence that asthma is associated with an increase in psychiatric dis-
orders (depression, anxiety, distress and somatization). The purpose of this study was to assess the pres-
ence of psychiatric disorders in adult asthmatic patients and to examine its relationship to asthma control.
Methods: A cross-sectional case-control study was conducted on 134 subjects (65 healthy volun-
teers, 69 asthmatic patients). The asthmatic patients were divided into 3 groups, according to GINA
guidelines (GINA, 2010) [2] criteria for asthma control, and were subsequently compared to control
groups in terms of demographic, clinical, and spirometric data, as well as The Four-Dimensional
Symptom Questionnaire to assess psychological symptoms.
Results: The sample was predominantly female 49 patients (71%). Of the 69 patients, 32 (46%)
were classiﬁed as having uncontrolled asthma. Somatization, anxiety, depression, distress levels were
higher among asthma patients compared to control and the difference was statistically signiﬁcant
(p< 0.05). High levels of somatization and distress were found among uncontrolled asthma cases
compared to partially and controlled cases with no statistically signiﬁcant difference (p> 0.05 and
p> 0.05, respectively).High levels of anxietywere foundamonguncontrolled andpartially controlled
asthma cases compared to controlled caseswith no statistically signiﬁcant difference. Lowgrade depres-
sion levels were noticed among controlled cases. High levels of anxiety were found among uncontrolled
and partially controlled asthma cases compared to controlled cases with no statistically signiﬁcant dif-
ference (p> 0.05 and p> 0.05, respectively). There was a negative weak correlation between psychi-
atric symptomsand age, duration of asthmaand forced expiratory volume in the ﬁrst second (p> 0.05).
Conclusions: Asthmatic patients are at high risk of psychiatric problems, particularly depression,
anxiety and somatization. Asthmatic patients need psychotherapy besides their medication of asthma
to obtain better asthma out come and management.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).rculosis.
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Bronchial asthma is a chronic inﬂammatory condition which is
considered as a major cause of disability and death [1]. The
prevalence of asthma has been increased in recent decades; it
affects about 300 million people world-wide which brings
about high socioeconomic costs and an increase in mortality
and morbidity [2]. The disease is characterized by sudden
and unexpected attacks of shortness of breath, thus asthma
attacks are a real threat for life in these patients [3].
It makes sense that asthma signiﬁcantly affects psychologi-
cal health because its impact on activities, sleep and social life
of patients. On the other hand, psychological factors may be a
risk factor for exacerbation of this disorder [4].
Asthma presents the most profound links between psycho-
logical, social, biological and physiological factors [5]. More
recent hypotheses regarding the link between asthma and psy-
chological factors are describing asthma as a classic psy-
chosomatic disorder caused by speciﬁc psychological conﬂicts
[6].
Two-thirds of patients with asthma are anxious during the
acute attack. Anxiety symptoms in asthmatics have been
revealed as strong predictors of respiratory illness in those
patients [7].
On the other hand, some negative emotions (fear, panic,
anger, and depression) are involved in a ﬂuctuating process
of bronchoconstriction of the airways, leading to worse crises
of asthma [8]. But, these emotions are not severe enough to be
classiﬁed as psychiatric disorders, but can lead to initiation or
worsening of asthma, directly by psychophysiological effects
or indirectly by neglecting self-management of the illness.
Conversely, these emotions can also be worsened by asthma
itself [9]. Depression is also associated with autonomic dysreg-
ulation leading to a cholinergic or vagal bias (i.e., vagal over
sympathetic reactivity) which increases airway instability in
asthma [10]. Stress exposure increases the risk of developing
asthma. In some patients, stress is the essential trigger for
asthma attacks [11].
Patients and methods
This study was across-sectional case-control conducted on 134
subjects (65 healthy volunteers, 69 asthmatic patients) who
were recruited from outpatient clinic of the Mansoura
University Hospitals, from April 2014 to December 2014.
The subjects were included after providing a written informed
consent.Table 1 Psychiatric symptoms in asthma patients and control.
Asthma patients
N= 69
Control
N= 65
p value
Group A Group B
Median (min–max)
Somatization 17(0–33) 8(0–30) <0.001
Anxiety 9(0–23) 4(0–20) <0.001
Depression 3(0–12) 1(0–12) <0.001
Distress 16(0–34) 10(0–32) <0.01The asthmatic patients were divided into 3 groups, accord-
ing to GINA guidelines [2] criteria for asthma control.
Group A: included 69 asthmatic patients.
Group B: included 65 healthy volunteers.
Group A was divided into 3 groups.
Group I: included 32uncontrolled asthmatic patients.
Group II: included 10 partially controlled asthmatic
patients.
Group III: included 27 controlled asthmatic patients.
All study subjects were considered eligible for the study if
they were conﬁrmed to the following criteria.
Inclusion criteria
1. Conﬁrmed asthmatic patient.
2. Non-smoker.
3. No exacerbation, chest infection in the last month.
4. No other respiratory disorders like tuberculosis, cystic
ﬁbrosis, bronchiectasis.
5. No other systemic disease hepatic, renal, diabetic, malig-
nancy, autoimmune diseases.
6. Pulmonary function and answering the questionnaire on
the same day.
7. No history of psychiatric disorder.
This study was designed to assess common psychological
symptoms (anxiety, depression, stress and somatization), age,
sex, duration of asthma and pulmonary function (forced
expiratory volume (FEV1)) in asthmatic patients.
Study deﬁnition
Distress
Characteristic distress symptoms are worry, irritability, ten-
sion, listlessness, poor concentration, sleeping problems and
demoralization.
Depression and anxiety
Because distress symptoms virtually always accompany mood
and anxiety disorders, it seems difﬁcult to differentiate distress
from depression and anxiety. When distress is separated from
depression we are left with anhedonia and depressive thoughts.
These symptoms are considered to represent the core symp-
tomatology of major depression. When we separate distress
from anxiety, we are left with irrational fears, anticipation
anxiety and avoidance behavior.
Somatization
Somatization is a tendency to experience medically unex-
plained somatic symptoms, to attribute them to physical ill-
ness, and to seek medical help for them [12].
The Four-Dimensional Symptom Questionnaire (4DSQ)
The 4DSQ is a self-report questionnaire comprising 50 items
distributed over four scales. The items are worded as questions
similar to those that can be asked in everyday primary care
practice. The reference period is ‘‘the past week’’. For example,
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tated?’’ The 4DSQ does not contain any positive affect ques-
tions, nor any other ‘‘reversed’’ worded questions. The
response categories are also worded as normal answers to clini-
cal questions: ‘‘no’’, ‘‘sometimes’’, ‘‘regularly’’, ‘‘often’’, ‘‘very
often or constantly’’.
In order to arrive at scale scores, the responses are scored as
0 for ‘‘no’’, 1 for ‘‘sometimes’’ and 2 for the other response
categories, and the item scores are summated to scale scores.
The distress scale contains 16 items and has a score range of
0–32, the Depression scale contains 6 items and has a range
of 0–12, the Anxiety scale contains 12 items and has a range
of 0–24, and the Somatization scale contains 16 items and
has a range of 0–32 [12].
The 4DSQ is available as a Dutch and an English version
[13]. We took the English version after approval from the
author. The Arabic version was obtained through a procedure
of translation into Arabic and back-translation into English.
Statistical analysis
 The results are expressed as means and standard deviations
or as medians and interquartile ranges. Categorical vari-
ables were compared using the Chi-square test or Fisher’s
exact test. Depending on the distribution, continuous
variables were compared by the unpaired t-test or
Mann–Whitney test. Values of p< 0.05 were considered
statistically signiﬁcant. Statistical analyses were performed
using the statistical freeware R, version 2.10.1 (R
Development Core Team, 2009).Table 2 Depression among studied asthmatic patients.
Un controlled N= 32(46%) Partially
Group I Group II
Low 26(81.2) 9(90)
Moderate 6(8.8) 1(10)
Total median (min–max) 3(0–12) 2(0–12)
Table 3 Distress symptoms among studied asthmatic patients.
Un controlled N= 32(46%) Partially
Group I Group II
Low 9(28.1) 5(50)
Moderate 11(34.4) 3(30)
High 12(37.5) 2(20)
Total median (min–max) 17(0–34) 13(5–31)
Table 4 Anxiety symptoms among studied asthmatic patients.
Un controlled N= 32(46%) Partially
Group I Group II
Low 5(15.6) 3(30)
Moderate 4(12.5) 1(10)
High 23(71.9) 6(60)
Total median (min–max) 9(0–23) 9(2–20) Internal consistency reliability analysis was Cronbach’s
alpha = 0.74.
Results
All study subjects were age and sex matched. The mean age of
asthmatic patients Group A was 31.9 ± 9.4, while the control
group Group B was 33.6 ± 8.2.
49(71%) of Group A (asthmatic patients) were females,
while 50(77%) of Group B (control subjects) were females.
Somatization, anxiety, depression, distress levels were
higher among asthma patients compared to control and the
difference was statistically signiﬁcant (p< 0.05) (Table 1).
Low grade depression levels were noticed among controlled
asthma cases, however total scores did not differ signiﬁcantly
between them (p> 0.05) (Table 2).
The highest levels of distress were noticed among uncon-
trolled asthma patients compared to partially and controlled
cases with no statistically signiﬁcant difference (p> 0.05)
(Table 3).
The highest levels of anxiety were found among uncon-
trolled and partially controlled compared to controlled asthma
cases with no statistically signiﬁcant difference (p> 0.05)
(Table 4.
The highest levels of somatization were noticed among
uncontrolled asthma patients compared to partially and con-
trolled cases with no statistically signiﬁcant difference
(p> 0.05) (Table 5)controlled N= 10(15%) Controlled N= 27(39%) p value
Group III
25(92.6) >0.05
2(7.4)
3(0–10) >0.05
controlled N= 10(15%) Controlled N= 27(39%) p value
Group III
9(33.3) >0.05
11(40.7)
7(25.9)
14(0–27) >0.05
controlled N= 10(15%) Controlled N= 27(39%) p value
Group III
8(29.6) >0.05
3(11.1)
16(59.3)
6(1–18) >0.05
Table 5 Somatization symptoms among studied asthmatic patients.
Un controlled N= 32(46%) Partially controlled N= 10(15%) Controlled N= 27(39%) p value
Group I Group II Group III
Low 4(12.5) 3(30) 9(33.3) >0.05
Moderate 18(56.3) 4(40) 11(40.7)
High 10(31.3) 3(30) 7(25.9)
Total median (min–max) 17.7 ± 7.04 15.5 ± 6.9 14.5 ± 8.4 >0.05
Table 6 Correlation between psychiatric symptoms and
clinical characteristics of asthma patients.
Asthma duration Age FEV1
Somatization r .045 .078 .042
p >0.05 >0.05 >0.05
Anxiety r .060 .200 .026
p >0.05 >0.05 >0.05
Depression r .001 .107 .071
p >0.05 >0.05 >0.05
Distress r .008 .061 .010
p >0.05 >0.05 >0.05
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ric symptoms and age, duration and FEV1 (p> 0.05)
(Table 6).
Discussion
Psychological factors may inﬂuence the symptoms and man-
agement of asthma, and numerous pathways may contribute
to the links between asthma and psychiatric disease states such
as depression [14].
In this study, we found that somatization, anxiety, depres-
sion, distress levels were higher among asthma patients com-
pared to control and the difference was statistically
signiﬁcant (p< 0.05).
High levels of somatization were found among uncon-
trolled asthma cases compared to partially and controlled
cases with no statistically signiﬁcant difference (p> 0.05).
Also, high levels of anxiety were found among uncontrolled
and partially controlled asthma cases compared to controlled
cases with no statistically signiﬁcant difference (p> 0.05).
Low grade depression levels were noticed among controlled
asthmatic cases, however total scores did not differ signiﬁ-
cantly between them (p> 0.05). The highest levels of distress
were noticed among uncontrolled asthma patients compared
to partially and controlled cases with no statistically signiﬁcant
difference (p> 0.05).Similar results were found in recent stud-
ies such as [5,8,14,15].
Studies examining comorbidity of asthma and mental dis-
orders suggest that adults with asthma are at increased risk
of manifesting major depressive disorder or, anxiety disorders
including generalized anxiety disorder, panic disorder, post-
traumatic stress disorder and social phobia [16].The presence
of a chronic and potentially life-threatening illness may exertenough stress that an anxiety or depressive disorder emerges
in vulnerable patients. As a consequence, epidemiologic
associations between major depressive disorder (MDD) and
asthma might be apparent but not reﬂect a shared patho-
physiologic vulnerability. Alternatively, there may be aspects
of dysregulation in key biologic systems, such as the neuroen-
docrine stress response or cytokine system, that predispose
people to both asthma and psychiatric illnesses independent
of the psychological impact of one chronic illness on the other
[14]. Alterations in the Hypothalamic Pituitary Adrenal Axis
(HPA) axis [17], immune System [18] and the autonomic ner-
vous system (ANS) [19]) may explain the co-occurrence of
these conditions.
There was a negative weak correlation between psychiatric
symptoms and age, duration of asthma and forced expiratory
volume in the ﬁrst second (p> 0.05).
Conclusion
Distress and psychiatric illnesses, particularly depression, anxi-
ety and somatization occur at higher rates in individuals with
asthma than in the general population. More research is
required to understand the environmental and genetic factors
involved in this association. A relation was noticed between
the psychological status of asthmatic patients and asthma con-
trol. These coexisting psychiatric disorders often remain
undiagnosed without psychiatric assessment. So, they should
be diagnosed and treated by Pharmacological and non
pharmacological therapies as soon as possible, to improve
patients’ outcome and achieve the best control of asthma.
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